Rudenko S V, Nipot E E
Institute for Problems of Cryobiology and Cryomedicine, National Academy of Sciences of the Ukraine, Kharkov, Ukraine.
Biochem J. 1996 Aug 1;317 ( Pt 3)(Pt 3):747-54. doi: 10.1042/bj3170747.
The ability of the peptides melittin, [Ala-14]melittin (P14A) and whole bee venom to lyse red blood cells (RBC) and to cause shape transformation, binding, partitioning and changes in volume of the cells during haemolysis, as well as the action of the bivalent cations Zn2+ and Ca2+, chlorpromazine, albumin and plasma on the peptide-induced haemolysis of RBC in high ionic-strength solution, have been investigated. The protective effect of all inhibitors depends on whether they have been added to the media before or after the cells. When added before the cells they reduced significantly the rate of peptide-induced haemolysis and shape transformation. The effect was maximal when agents acted simultaneously after introduction of the cells into the media containing both inhibitors and peptides. Incubation of the cells in isotonic solution before the addition of peptides enhanced 2-3-fold the RBC susceptibility (i.e. rate of haemolysis) to lytic action of the same amount of peptides, and increased the order of the haemolytic reaction, although the power law coefficient did not exceed a value of 2 for all peptides, suggesting that haemolysis is attributable to the monomeric or dimeric forms of the peptides. Partition coefficients were of the order of approximately 10(6) M-1, and P14A possessed a value 3-fold larger compared with melittin and bee venom, which correlated with its enhanced haemolytic activity. The protective action of inhibitors against peptide-induced haemolysis has been explained on the basis of their ability to compete with peptide binding at an early stage of peptide-membrane interaction, and not as a result of inhibition of a pre-existing peptide-induced pore. Whereas melittin increased the volume of RBC during haemolysis, P14A, melittin in the presence of phospholipase A2 or bee venom, reduced the volume in a concentration-dependent manner. The present data reveal the significant role of the initial stage of peptide-membrane interaction and peptide structure in the mechanism of haemolysis. These data are not consistent with a lipid-based mechanism of peptide-induced haemolysis, indicating that the mode of peptide-protein interaction is an important and decisive step in the haemolytic mechanism. It should be noted that data (in the form of three additional Tables) on the ability of inhibitors to protect cells from haemolysis when inhibitor and peptide act simultaneously are available. They are reported in Supplementary Publication SUP 50178, which has been deposited at the British Library Document Supply Centre, Boston Spa, Wetherby, West Yorkshire LS23 7BQ, U.K., from whom copies can be obtained on the terms indicated in Biochem. J. (1996) 313, 9.
研究了蜂毒肽、[丙氨酸-14]蜂毒肽(P14A)和全蜂毒裂解红细胞(RBC)的能力,以及在溶血过程中引起细胞形状转变、结合、分配和体积变化的能力,同时还研究了二价阳离子Zn2+和Ca2+、氯丙嗪、白蛋白和血浆对高离子强度溶液中肽诱导的RBC溶血的作用。所有抑制剂的保护作用取决于它们是在细胞之前还是之后添加到培养基中。在细胞之前添加时,它们显著降低了肽诱导的溶血速率和形状转变。当细胞被引入含有抑制剂和肽的培养基后,这些试剂同时起作用时,效果最为显著。在添加肽之前将细胞在等渗溶液中孵育,可使RBC对相同量肽的裂解作用的敏感性(即溶血速率)提高2至3倍,并增加溶血反应的级数,尽管所有肽的幂律系数均不超过2,这表明溶血归因于肽的单体或二聚体形式。分配系数约为10(6) M-1,与蜂毒肽和蜂毒相比,P14A的值大3倍,这与其增强的溶血活性相关。抑制剂对肽诱导的溶血的保护作用已根据它们在肽-膜相互作用早期与肽结合竞争的能力来解释,而不是由于抑制预先存在的肽诱导的孔。蜂毒肽在溶血过程中增加RBC的体积,而P14A、磷脂酶A2存在时的蜂毒肽或蜂毒则以浓度依赖的方式降低体积。目前的数据揭示了肽-膜相互作用的初始阶段和肽结构在溶血机制中的重要作用。这些数据与基于脂质的肽诱导溶血机制不一致,表明肽-蛋白质相互作用模式是溶血机制中的一个重要且决定性的步骤。应当指出,有关于抑制剂和肽同时作用时保护细胞免受溶血能力的数据(以另外三个表格的形式)。这些数据发表在补充出版物SUP 50178中,该出版物已存放在英国西约克郡韦瑟比波士顿温泉市的大英图书馆文献供应中心,其LS23 7BQ,可按照《生物化学杂志》(1996年)313, 9中所示的条件从该处获取复印件。